glp 1 physiology Shared earlier this week: GLP-1 and pharmacology along the #gut-brain axis As part of the JCI's Review Series on Clinical Innovation and Scientific Progress in GLP-1 Medicine, Lisa R. Beutler summarizes GLP-1 physiology in obesity and

This study has avoided the confounding effects of chronic antidiabetic treatment, because these treatments did not show any significant difference between GTE and placebo groups

The key parameters measured were right ventricular end-diastolic area (RVEDA), right ventricular fractional area change (RVFAC), and tricuspid annular plane systolic excursion (TAPSE)

SLC25A22 as a Key Mitochondrial Transporter Against Ferroptosis by Producing Glutathione and Monounsaturated Fatty Acids

Clearly this tactic provided a broadly useful opioid deterrent, said study first author Atsushi Kimishima, a research associate in the Janda laboratory